12 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisMASH With Fibrosis; NASH With FibrosisRecruitingPhase 32026-10-06NCT06215716
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHDigestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver diseaseRecruitingPhase 32026-09-21NCT06528314
Phase 2 Study of ADX-038 in Participants With Geographic AtrophyGeographic Atrophy Secondary to Age-related Macular DegenerationRecruitingPhase 22026-09-03NCT06990269
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary EmbolismEmbolism, Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolismRecruitingPhase 42026-05-22NCT04263038
Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal DiseaseChronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Inflammation, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postprandial Hypoglycemia, Urogenital Diseases, chronic renal failure syndrome, glucose metabolism disease, hypoglycemia, kidney disorder, kidney failure, metabolic disease, urinary system disorderNot yet recruitingPhase 22026-05-12NCT07580079
Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac SurgeryInfarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderActive, not recruitingNot stated2026-05-05NCT05859620
Impact of Core Muscle Training on Incisional Hernia and Pain After Abdominal SurgeryHernia, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative ComplicationsRecruitingNot applicable2026-05-05NCT03808584
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver diseaseActive, not recruitingPhase 32026-04-30NCT06161571
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-DiaNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitusRecruitingPhase 22026-02-25NCT06047262
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 DiabetesNutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitusRecruitingPhase 32026-01-26NCT06630585
Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed DiabetesNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitusRecruitingNot applicable2025-02-14NCT03827382
The SwissPrEPared StudyHIV Preexposure ProphylaxisRecruitingNot stated2023-04-06NCT03893188